
Align Technology (ALGN) Stock Forecast & Price Target
Align Technology (ALGN) Analyst Ratings
Bulls say
Align Technology demonstrated solid growth in its operations, with teen case starts increasing by 8.3% year-over-year, attributed largely to strong performance in the Asia-Pacific and EMEA regions. The third quarter saw a total of 647.8k new Invisalign case starts, reflecting a 4.9% year-over-year increase, and the company expects sequential growth in sales volumes and average selling prices (ASPs) for the fourth quarter, with adjusted operating margins projected to rise to 26%. Additionally, despite a slight miss in clear aligner sales of $804.6 million in the third quarter, the growth in Scanner/Services sales by 5.6% year-over-year to $207.8 million indicates a strong demand for its intraoral scanners, contributing positively to Align Technology's overall revenue outlook.
Bears say
Align Technology's stock outlook is negatively impacted by its disappointing adjusted earnings per share (EPS) of $2.49, which fell below market expectations of $2.57, signaling weak operational performance. Additionally, the company's adjusted gross margin (GM%) decreased by 40 basis points year-over-year to 70.5%, reflecting the challenges faced in revenue generation, particularly leading to an operating margin (OM%) that came in significantly below expectations at 21.3%. Lastly, the management's downward revision of its 2025 growth projections for clear aligner volume and revenue growth highlights ongoing concerns regarding revenue visibility and overall market conditions.
This aggregate rating is based on analysts' research of Align Technology and is not a guaranteed prediction by Public.com or investment advice.
Align Technology (ALGN) Analyst Forecast & Price Prediction
Start investing in Align Technology (ALGN)
Order type
Buy in
Order amount
Est. shares
0 shares